Literature DB >> 30120123

Dysregulated Calcium Homeostasis in Cystic Fibrosis Neutrophils Leads to Deficient Antimicrobial Responses.

Frank H Robledo-Avila1, Juan de Dios Ruiz-Rosado1, Kenneth L Brockman1, Benjamin T Kopp1,2, Amal O Amer3, Karen McCoy2,4, Lauren O Bakaletz1,4, Santiago Partida-Sanchez5,4.   

Abstract

Cystic fibrosis (CF), one of the most common human genetic diseases worldwide, is caused by a defect in the CF transmembrane conductance regulator (CFTR). Patients with CF are highly susceptible to infections caused by opportunistic pathogens (including Burkholderia cenocepacia), which induce excessive lung inflammation and lead to the eventual loss of pulmonary function. Abundant neutrophil recruitment into the lung is a key characteristic of bacterial infections in CF patients. In response to infection, inflammatory neutrophils release reactive oxygen species and toxic proteins, leading to aggravated lung tissue damage in patients with CF. The present study shows a defect in reactive oxygen species production by mouse Cftr-/- , human F508del-CFTR, and CF neutrophils; this results in reduced antimicrobial activity against B. cenocepacia Furthermore, dysregulated Ca2+ homeostasis led to increased intracellular concentrations of Ca2+ that correlated with significantly diminished NADPH oxidase response and impaired secretion of neutrophil extracellular traps in human CF neutrophils. Functionally deficient human CF neutrophils recovered their antimicrobial killing capacity following treatment with pharmacological inhibitors of Ca2+ channels and CFTR channel potentiators. Our findings suggest that regulation of neutrophil Ca2+ homeostasis (via CFTR potentiation or by the regulation of Ca2+ channels) can be used as a new therapeutic approach for reestablishing immune function in patients with CF.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30120123      PMCID: PMC6143431          DOI: 10.4049/jimmunol.1800076

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  73 in total

1.  Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity.

Authors:  Kathleen D Metzler; Tobias A Fuchs; William M Nauseef; Dominique Reumaux; Joachim Roesler; Ilka Schulze; Volker Wahn; Venizelos Papayannopoulos; Arturo Zychlinsky
Journal:  Blood       Date:  2010-10-25       Impact factor: 22.113

2.  Neutrophil chemotaxis in acutely infected and clinically stable cystic fibrosis patients.

Authors:  B Sener; G Hasçelik; U Ozçelik; A Günalp; A Göçmen
Journal:  Pediatr Int       Date:  1999-10       Impact factor: 1.524

3.  Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.

Authors:  A M Jones; M E Dodd; J R W Govan; V Barcus; C J Doherty; J Morris; A K Webb
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

4.  Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis.

Authors:  M Kolpen; C R Hansen; T Bjarnsholt; C Moser; L D Christensen; M van Gennip; O Ciofu; L Mandsberg; A Kharazmi; G Döring; M Givskov; N Høiby; P Ø Jensen
Journal:  Thorax       Date:  2009-10-21       Impact factor: 9.139

5.  Restoration of NET formation by gene therapy in CGD controls aspergillosis.

Authors:  Matteo Bianchi; Abdul Hakkim; Volker Brinkmann; Ulrich Siler; Reinhard A Seger; Arturo Zychlinsky; Janine Reichenbach
Journal:  Blood       Date:  2009-06-18       Impact factor: 22.113

6.  Synergy of cAMP and calcium signaling pathways in CFTR regulation.

Authors:  Zoltan Bozoky; Saumel Ahmadi; Tal Milman; Tae Hun Kim; Kai Du; Michelle Di Paola; Stan Pasyk; Roman Pekhletski; Jacob P Keller; Christine E Bear; Julie D Forman-Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-27       Impact factor: 11.205

Review 7.  Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis.

Authors:  Laura A Porter; Joanna B Goldberg
Journal:  Front Cell Infect Microbiol       Date:  2011-11-18       Impact factor: 5.293

8.  The p47phox mouse knock-out model of chronic granulomatous disease.

Authors:  S H Jackson; J I Gallin; S M Holland
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

Review 9.  Regulation of superoxide production in neutrophils: role of calcium influx.

Authors:  Sabrina Bréchard; Eric J Tschirhart
Journal:  J Leukoc Biol       Date:  2008-06-10       Impact factor: 4.962

10.  Intrinsic predisposition of naïve cystic fibrosis T cells to differentiate towards a Th17 phenotype.

Authors:  Rahul Kushwah; Stéphane Gagnon; Neil B Sweezey
Journal:  Respir Res       Date:  2013-12-17
View more
  20 in total

1.  Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis.

Authors:  Benjamin T Kopp; James Fitch; Lisa Jaramillo; Chandra L Shrestha; Frank Robledo-Avila; Shuzhong Zhang; Sabrina Palacios; Fred Woodley; Don Hayes; Santiago Partida-Sanchez; Octavio Ramilo; Peter White; Asuncion Mejias
Journal:  J Cyst Fibros       Date:  2019-08-29       Impact factor: 5.482

2.  Exposure of Pseudomonas aeruginosa to bactericidal hypochlorous acid during neutrophil phagocytosis is compromised in cystic fibrosis.

Authors:  Nina Dickerhof; Vivienne Isles; Philip Pattemore; Mark B Hampton; Anthony J Kettle
Journal:  J Biol Chem       Date:  2019-07-24       Impact factor: 5.157

3.  Pharmacological inhibitors of the cystic fibrosis transmembrane conductance regulator exert off-target effects on epithelial cation channels.

Authors:  JinHeng Lin; Sean M Gettings; Khaoula Talbi; Rainer Schreiber; Michael J Taggart; Matthias Preller; Karl Kunzelmann; Mike Althaus; Michael A Gray
Journal:  Pflugers Arch       Date:  2022-10-07       Impact factor: 4.458

4.  Tissue-localized immune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection.

Authors:  Don Hayes; Rajni Kant Shukla; Yizi Cheng; Emrah Gecili; Marlena R Merling; Rhonda D Szczesniak; Assem G Ziady; Jason C Woods; Luanne Hall-Stoodley; Namal Pm Liyanage; Richard T Robinson
Journal:  JCI Insight       Date:  2022-06-22

5.  Control the platelets, control the disease: A novel cystic fibrosis hypothesis.

Authors:  Siobhan Branfield; A Valance Washington
Journal:  J Thromb Haemost       Date:  2020-05-28       Impact factor: 5.824

6.  Neutrophil dysfunction in cystic fibrosis.

Authors:  Lael M Yonker; Anika Marand; Sinan Muldur; Alex Hopke; Hui Min Leung; Denis De La Flor; Grace Park; Hanna Pinsky; Lauren B Guthrie; Guillermo J Tearney; Daniel Irimia; Bryan P Hurley
Journal:  J Cyst Fibros       Date:  2021-02-13       Impact factor: 5.482

Review 7.  Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation.

Authors:  Meraj A Khan; Zubair Sabz Ali; Neil Sweezey; Hartmut Grasemann; Nades Palaniyar
Journal:  Genes (Basel)       Date:  2019-02-26       Impact factor: 4.096

8.  Caspase-11 Mediates Neutrophil Chemotaxis and Extracellular Trap Formation During Acute Gouty Arthritis Through Alteration of Cofilin Phosphorylation.

Authors:  Kyle Caution; Nicholas Young; Frank Robledo-Avila; Kathrin Krause; Arwa Abu Khweek; Kaitlin Hamilton; Asmaa Badr; Anup Vaidya; Kylene Daily; Hawin Gosu; Midhun N K Anne; Mostafa Eltobgy; Duaa Dakhlallah; Sudha Argwal; Shady Estfanous; Xiaoli Zhang; Santiago Partida-Sanchez; Mikhail A Gavrilin; Wael N Jarjour; Amal O Amer
Journal:  Front Immunol       Date:  2019-11-15       Impact factor: 7.561

9.  Consequences of CRISPR-Cas9-Mediated CFTR Knockout in Human Macrophages.

Authors:  Shuzhong Zhang; Chandra L Shrestha; Benjamin L Wisniewski; Hanh Pham; Xucheng Hou; Wenqing Li; Yizhou Dong; Benjamin T Kopp
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

10.  Intravascular adhesion and recruitment of neutrophils in response to CXCL1 depends on their TRPC6 channels.

Authors:  Otto Lindemann; Jan Rossaint; Karolina Najder; Sandra Schimmelpfennig; Verena Hofschröer; Mike Wälte; Benedikt Fels; Hans Oberleithner; Alexander Zarbock; Albrecht Schwab
Journal:  J Mol Med (Berl)       Date:  2020-01-16       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.